13 participants
Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-16
- Start Date:
- 2017-03-20
- Completion:
- 2024-09-24
Conditions
- Head and Neck Cancer
Interventions
- DRUG